Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral ...
Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...
Athabasca Oil Corporation (TSX: ATH) ("Athabasca” or the "Company”) is pleased to announce that the Toronto Stock Exchange ("TSX”) has approved the renewal of the Corporation's normal course issuer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results